Introduction
============

Type 2 diabetes (T2D) is one of the leading complex diseases. It is most commonly seen in older adults, but it is increasingly seen in children, adolescents, and younger adults due to rising levels of obesity, physical inactivity, and poor diet ([@B19]). T2D is mainly a glucose metabolism disorder, and is currently believed to be a heterogeneous disease. One important fact is that the development of T2D involves multiple tissues ([@B47]; [@B7]; [@B34]; [@B39]). Those tissues include white adipose tissue, skeletal muscle, and liver (shortly written as adipose, muscle, and liver hereafter). Each tissue has its own characteristics induced by T2D. One important and challenging problem is to explore the cross talk among multiple tissues since T2D is a systemic disease involving complicated synergy and regulation among different tissues. Exploring its underlying mechanisms across multiple tissues will be helpful for personalized therapy and precision medicine in T2D treatment. However, most existing studies focused on single tissue only ([@B28]; [@B24]; [@B1]).

On the other hand, it has been accepted that although molecules are basic components of cellular machinery, a complex disease is generally caused not from the malfunction of individual molecules but from the interplay of a group of correlated molecules or a network. Thus, with the development of bioinformatics and high-throughput data, network-based characterization of complex diseases, including T2D, has been invaluable to integrate and interpret functional genomics datasets and identify new biomarkers or modules to better classify patients into subtypes. Such approaches are much more powerful than approaches that examine a single gene at a time ([@B4]; [@B17]; [@B46]; [@B29]; [@B45]; [@B18]; [@B48]). However, most methods tended to characterize the complex programs using sets of genes, while the interaction (described as edge in biological network) information was not fully utilized in final prediction or analysis. Therefore, such methods cannot inform us on the functional discrepancies between gene pairs that are perturbed under disease.

Here, we propose a multi-level comparative framework mostly focusing on interactions across different representative tissues to gain a broader and further understanding of T2D. The whole framework can be divided into two phases and each phase is comprised of several major steps ([Figure 1](#F1){ref-type="fig"}). The first phase is disease network construction, to effectively characterize the abnormal information response to disease. In recent years, many efforts have been made to extract disease information through selecting co-expression gene pairs whose expressions were highly correlated across samples. These methods were under the hypothesis that genes associated with the same disorder tend to share common functional features, i.e., their protein products tend to interact with each other. However, genes show highly correlated patterns of expression in one biological state, but not in another, i.e., they may not be highly correlated across the entire dataset, and therefore they fail to be picked out by co-expression based methods ([@B44]; [@B13]). For this reason, we proposed a method based on finding 'diverse interactions' according to the discrepancy between correlations in different phenotypes by extending our previous work ([@B38]). Beyond our previous work, we further considered the weight of interactions together, thus all the diverse interactions along with their discrepant coefficients which composed the weighted diverse interaction network (WDIN). Indeed, this WDIN would unravel the complexity of gene-pair regulation in the complex process regarding different tissues. In addition, it should be noted that during the computation of adjacency matrix for WDIN, we proposed to calculate the discrepant coefficient based on genes' ranks instead of expression values. Such an operation would weaken the biased influence caused by different expression levels in different tissues and experiments and consequently provide a uniform scale for all samples independent of the dynamic range of a data profile ([@B23]; [@B3]).

![Schematic illustration of the multi-level comparative framework of this study. Two major phases are included, network construction and multi-level analysis. WDIN is the constructed disease network, and MCM is the identified key module.](fgene-10-00252-g001){#F1}

The second phase is multi-level analysis based on the inferred disease network. This phase is composed of network-, gene-, and module-level analysis. Network-level analysis gives an overall cross-tissue study about the T2D based on the constructed original tissue-dependent WDIN. Gene-level analysis is carried out through discussing the prioritized nodes of WDIN which can provide a local and delicate explanation for the disease. The major step of this phase is to discover core modules and then derive a merged core module. Following module-level analysis could carefully and visibly illustrate the common and specific features belonging to different tissues. In this part, the random walk restart (RWR) algorithm is employed to rank genes and further extended to prioritize gene interactions. The clustering coefficient is introduced to enable identifying biological core modules composed of prioritized interactions.

In summary, we explore the tissue cross talk of T2D at gene-, module-, and network-level comparisons across different tissues to uncover hidden patterns and their biological implications from multi-tissues 'omic' data. Our multi-level comparative framework is shown in [Figure 1](#F1){ref-type="fig"}. We expect that our proposed multi-level analysis framework can be extended beyond gene expression level and discover new commonalities and specificities among tissues.

Materials and Methods {#s1}
=====================

Data Collection
---------------

### Tissue Dependent Gene Expression Data Retrieval

We obtained gene expression profiles from three rat tissues (white adipose, skeletal muscle, and liver) \[diabetes rats: Goto--Kakizaki (GK) rats; control rats: Wistar--Kyoto (WK) rats\] from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus database (access ID: GSE13268, GSE13269, and GSE13270) ([@B2]; [@B33]; [@B43]). The profile was composed of 31,099 probes. Our first filter eliminated the probe sets without the corresponding official symbol, leaving 25,345 genes for further consideration.

### T2D Associated Genes Collection

To provide support and verification for our work, we collected the canonically reported genes associated with T2D. These genes were gathered from Type II diabetes mellitus pathway (KEGG-Kyoto Encyclopedia of Genes and Genomes, H00409) which will be referred to as 'T2D-pathway genes.' In total, we obtained 50 T2D-pathway genes, among which 42 genes had gene expression aforementioned and were used in this study. Other T2D related genes were downloaded from the Rat Genome Database (RGD)^[1](#fn01){ref-type="fn"}^ in October 2018. In total, 515 genes were downloaded from RGD (referred to as RGD-reported genes), and only those that have been measured in GSE 13268-13270 were kept. Thus 303 RGD-reported genes were left.

### Protein--Protein Interaction Network Integration

Rat protein--protein interaction (PPI) network was integrated based on KEGG pathway and BioGRID (Biological General Repository for Interaction Datasets). Actually, not all the proteins in PPI network have corresponding gene expression values in expression profiles GSE13268-GSE13270. To carry out our cross-tissue analysis, we only reserved interactions whose two nodes have expressions in three tissues. Finally, the reserved interactions composed a network with 4,081 nodes (proteins) among 24,503 edges (interactions). This network was noted as 'background PPI network' with gene pair-wise expressions in our study.

Data Processing
---------------

In most studies about network biology such as the ones aimed at identifying network biomarkers of complex diseases, researchers usually collect gene expression data from multiple experiments. The expression profiles belonging to different experiments may represent different tissues, or different experiment conditions. Straightly pooling the expression profiles to construct various networks would ignore the underlying structure of the data, and the pooled estimates may be severely biased due to the heterogeneity of the experiments. Instead of pooling the expression data, we first ranked the genes by their expression values for each expression array, and then normalized the rank index for every gene. The normalized rank (z*-*score) was computed using the mean (μ) and standard deviation (σ) of the ranks of all genes along one sample which can be described as *z-*score = (x--μ)/σ. In subsequent computation and analysis, this normalized rank was used instead of expression value since it can reduce the data noise deriving from different experimental conditions and different tissues.

[Figure 2](#F2){ref-type="fig"} shows that the expression levels estimated by normalized ranks subject to normal distribution are more consistent, indicating that such ranking processing is a more valid procedure.

![The histograms of six gene expression profiles under different data processing strategies. **(A)** Histograms of gene expression in three tissues for two phenotypes. **(B)** Histograms of normalized gene expression in three tissues for two phenotypes. **(C)** Histograms of gene index based on ranking expression in three tissues for two phenotypes.](fgene-10-00252-g002){#F2}

Tissue-Dependent WDINs Construction
-----------------------------------

A WDIN was constructed for each tissue that was related to the query disease---T2D. The pipeline of constructing WDIN was as follows:

1.  For each gene pair in the integrated background PPI network, calculate its correlation respectively under normal (WK) and disease condition (GK) based on the tissue specific normalized expression ranks of their corresponding two genes.

2.  Choose the gene pair as our diverse interaction whose correlations own significant difference between two conditions, and all identified dysfunctional interactions compose the WDIN. The weight of each edge is the difference between two correlations under normal (WK) and disease (GK) conditions.

After the creation of the tissue-dependent WDIN for each tissue, each interaction was weighted by the diverse correlation of corresponding gene pair. For each interaction, the absolute value of its weight can reflect the degree of deviation of this interaction in different phenotypes (normal and disease), and the positive and negative property of the weight coefficient indicates whether the corresponding function is active or inactive in disease condition compared with normal condition, which would provide more information for medical biology. Subsequently, we noted the edge with positive weight as 'active edge,' and the edge with negative weight as 'inactive edge,' respectively.

Random Walk With Restart (RWR) on WDIN
--------------------------------------

### Rank Candidate Genes

We applied RWR algorithm to our constructed tissue-dependent WDINs. The goal is to rank genes in candidate sets based on their association level with T2D. RWR is a ranking algorithm which simulates a random walk on the network to compute the proximity between two nodes by exploiting the global structure of the network. It starts on a set of seed nodes, which is the set of genes known to be associated with a phenotype p (T2D in this work). The candidate genes are then ranked by the probability of the random walker reaching this node ([@B30]; [@B40]; [@B14]).

Each tissue-specific WDIN can be mathematically described as Γ = (*V*, ε, *w*), *V* is the gene set of WDIN's nodes, εis a set of undirected interactions between these genes (or their products), *uv* ∈ ε represents an interaction between *u* ∈ *V* and *v* ∈ *V*, *w*(*u*, *v*) indicates the weight coefficient of interaction *uv* ∈ ε. The set of interacting partners of a gene *v* ∈ *V* is defined as *N*(*v*) = {*u* ∈ *V* } : *uv* ∈ ε and the total reliability of known interactions of *v* is defined as *W*(*v*) = ∑~u∈\ N(v)~ *w*(*uv*).

Let *p*~0~ be the initial probability vector and *p*~s~ be a vector in which the i-th element holds the probability of finding the random walker at node *i* at step*s*. Algorithmically, random-walk based association scores can be computed iteratively as follows:
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Here, η denotes the weight of the network. γ ∈ (0,1)is a user-defined restart probability to adjust the preference between the importance of a protein or gene with respect to the seed set and network topology. Numerical results show that γ = 0.3 is optimal for RWR's performance ([@B11]; [@B12]). Thus, γ is set to 0.3 for RWR in this paper. *M* is the transition matrix of the Γ, the transition probability from gene *u* to gene *v* can be described as follows,
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The seed set is composed of T2D-pathway genes covered by the WDIN, and the candidate set contains other nodes of WDIN excluding these seed genes. The RGD-reported genes would be used as test genes to verify the performance of applying RWR to WDINs. The details will be shown in the Results section.

### Rank Candidate Edges

Based on the ranked candidate nodes, we further prioritized the edges of WDIN for each tissue. In detail, given an edge, we assigned an index to the edge according to the ranks of its two linked nodes to indicate its association degree to the studied disease. Theoretically and computationally, using the average ranks of its two nodes as the edge's index would meet the requirement. Then all the edges would be ranked in ascending order according to their assigned indices. An edge having higher rank (with smaller rank value) is more closely associated with the studied disease. These sorted edges enable us to identify a minimal set composed of prioritized edges which can reflect plentiful information about the disease in the considered tissue. Such a set would be referred to as 'core module', which could provide some important information from another viewpoint.

Network/Module Comparison
-------------------------

We quantified the similarity of two networks based on edges. Given two different networks, we supposed the numbers of edges belonging to these two networks to be respectively *N*~1~ and N~2~. Then we calculated the number of edges that are present in both networks (common edges) noted as variable *n*. We defined variable *x*~1~ as the ratio of the number of common edges (*n*) to the number of edges in the first network (*N*~1~) and defined variable *x*~2~ as the ratio of the number of common edges (*n*) to the number of edges in the second network (*N*~2~). Using variables *x*~1~ and*x*~2~, we introduced a *S-*score as the harmonic mean of *x*~1~ and *x*~2~ ([@B36]; [@B21]). The formulae are as follows,
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Pathway and Motif Enrichment
----------------------------

Functional analyses about pathway and process enrichment have been carried out with the following ontology sources: GO Biological Processes, KEGG Pathway, Reactome Gene Sets. The analyses are performed through web tool Metascape^[2](#fn02){ref-type="fn"}^ ([@B41]).

Results
=======

Network-Level Analysis Based on Tissue-Dependent WDINs
------------------------------------------------------

In order to better capture the disease related information, for each tissue, we have designed a new way to infer a tissue-dependent WDIN through exacting the interactions with significant diverse correlations in different phenotypes. Instead of choosing disease related genes individually, we picked out such genes in pairs. An edge would be picked out if its corresponding genes were strongly correlated (the Spearman correlation coefficient is larger than or equal to some threshold, such as 0.8) under one strain while not (e.g., less than 0.2) in the other condition. Such an edge implicated that the interaction between the genes was obviously perturbed under the disease and hence noted as 'diverse interaction' in this work. Subtracting the correlation coefficient in normal state from the coefficient in disease state, we have the weight of each diverse interaction.

### Characteristics of WDINs

Through screening all edges in background PPI network, we identified 2,026/2,118/2,184 diverse edges among 1,710/1,783/1,793 nodes for adipose/muscle/liver respectively. We computationally validated these networks by examining the number of T2D-rpathway genes and RGD-reported genes covered by each tissue-dependent WDIN. We found that the created WDIN could hit most (exceed 83%) T2D-pathway genes and more than half RGD-reported genes ([Table 1](#T1){ref-type="table"}). This means that our designed way of constructing WDIN is effective, and through screening the background PPI network and cutting away those edges having loose or no association with the disease, the inferred WDINs could capture abundant disease related information with less edges.

###### 

Characteristics of three tissue-dependent WDINs.

  ![](fgene-10-00252-i001.jpg)   Number of nodes   Number of edges   Hits of 42 T2D-pathway genes   Hits of 303 RGD-reported genes
  ------------------------------ ----------------- ----------------- ------------------------------ --------------------------------
  Adipose                        2,026             1,710             35                             154
  Muscle                         2,118             1,783             36                             169
  Liver                          2,184             1,793             39                             162

We further investigated the Venn diagram for nodes of three tissue-dependent WDINs and disease related genes they covered ([Figure 3](#F3){ref-type="fig"}). From the Venn we can see that the percentage of specific genes in each WDIN ranges from 11.1 to 14.1%, and the housekeeping genes (genes appeared in three WDINs simultaneously) is at the level of 33.2% ([@B10]; [@B25]). The Venn about the coved T2D-related genes composed of T2D-pathway genes and RGD-reported genes presented a similar result.

![**(A)** Venn diagram of all genes in three tissue-dependent WDINs. **(B)** Venn diagram of T2D- related genes covered in three WDINs respectively.](fgene-10-00252-g003){#F3}

### Network Similarity Analysis

In addition to comparing networks based on network nodes through Venn diagram, we also carried out network edge comparison to further quantify the extent of shared and tissue-specific network components. Thus, we introduced *S*-score measure to assess the similarity between networks edges for each pair of tissues since it is a more sensitive measure for comparisons. Based on *S*-score ([Figure 4A](#F4){ref-type="fig"}), we found that the similarity between each pair of WDINs is low, which means that during the progress of T2D, three tissues possess evident tissue specificity. In this network comparison, adipose tissue and muscle tissue were indicated to emerge as the most similar dysfunctions caused by T2D among three insulin responsive tissues.

![Network-level comparison of three tissue-dependent WDINs. **(A)** Network similarity based on edges. **(B)** Heatmap of enriched terms across three tissue-specific gene lists, colored by *p*-values.](fgene-10-00252-g004){#F4}

### Cross-Tissue Functional Analysis Based on WDINS

To confirm the significant relation between tissue- dependent WDINs and T2D, the pathway and motif enrichment was conducted for each WDIN to categorize the genes participating in different biological functions or pathways.

#### Enrichment analysis on tissue non-specific genes

[Table 2](#T2){ref-type="table"} lists the top 20 enriched terms of pathway and biological process of 904 tissue non-specific genes. The well-known T2D related pathway- Insulin signaling pathway ranks in the 16th position. Most other listed pathways have been documented to be associated with T2D. For example, two pathways about cancer (pathways in cancer and proteoglycans in cancer) were enriched, and this is not surprising since cancer is quickly emerging as another pathological consequence of T2D ([@B35]). Due to the lack of adequate glucose uptake induced by dysfunction of insulin response, most pathways related to the cellular regulatory signal transduction of basic energy metabolism became abnormal, such as Chemokine, cAMP and Wnt signaling pathways and so on ([@B26]). As T2D is a well-known metabolic disease, the metabolic related pathways appeared to be abnormal, such as Purine metabolism and drug metabolic process.

###### 

Enriched terms of pathway and biological process of house-keeping genes.

  Category                  Description                              Count   \%        Log10(P)
  ------------------------- ---------------------------------------- ------- --------- ----------
  KEGG Pathway              Pathways in cancer                       174     19.3548   −100.0
  KEGG Pathway              Chemokine signaling pathway              112     12.4582   −100.0
  KEGG Pathway              Purine metabolism                        104     11.5684   −91.7492
  KEGG Pathway              Proteoglycans in cancer                  101     11.2347   −79.4258
  GO Biological Processes   Organophosphate biosynthetic process     139     15.4616   −70.6282
  KEGG Pathway              Oxytocin signaling pathway               83      9.2324    −69.5144
  KEGG Pathway              HTLV-I infection                         105     11.6796   −65.5991
  Reactome Gene Sets        Signaling by Receptor Tyrosine Kinases   105     11.6796   −64.0668
  KEGG Pathway              cAMP signaling pathway                   87      9.6774    −63.8028
  GO Biological Processes   Small molecule biosynthetic process      143     15.9065   −59.8328
  GO Biological Processes   Response to peptide                      138     15.3503   −58.5452
  GO Biological Processes   Drug metabolic process                   148     16.4627   −55.7688
  GO Biological Processes   Response to xenobiotic stimulus          108     12.0133   −54.4963
  GO Biological Processes   Response to toxic substance              141     15.6840   −52.1495
  KEGG Pathway              Insulin signaling pathway                67      7.4527    −52.0524
  GO Biological Processes   Response to inorganic substance          143     15.9065   −51.8458
  KEGG Pathway              Fluid shear stress and atherosclerosis   69      7.6751    −51.1151
  KEGG Pathway              Leukocyte transendothelial migration     61      6.7853    −50.3888
  KEGG Pathway              Wnt signaling pathway                    66      7.3414    −49.2176
  KEGG Pathway              Phosphatidylinositol signaling system    54      6.0066    −46.7635

#### Enrichment analysis on tissue specific genes

Some tissue-specific property can be displayed through the functional analysis of specific genes in three WDINs ([Figure 4B](#F4){ref-type="fig"}). For example, Drug metabolic appeared to be significant in liver-dependent WDIN enriched terms. Negative regulation of intracellular signal transduction and response to oxidative stress were found to be dysfunctional in liver-specific WDIN only, and didn't appear in the remaining two tissues. In addition, we found that overall the abnormal functions caused by T2D appear to be more similar in adipose and muscle, which is consistent with the result induced by network similarity based on *S*-score ([Figure 4A](#F4){ref-type="fig"}).

Gene-Level Analysis Based on Prioritized WDINs
----------------------------------------------

### Prioritizing WDINs Using RWR

To rank genes belonging to candidate sets based on their association level with T2D, we applied RWR to our three constructed tissue-dependent WDINs. The RWR method starts with the genes belonging to T2D pathway covered by each WDIN, and these genes are referred to as seed genes. The candidate set of genes includes other nodes of WDIN excluding the seed genes. After the random walking, the candidates are ranked according to the proximity of each gene to the genes in the seed set.

To verify the efficiency of random walk on the WDIN, we collected T2D related genes from RGD database. In all 303 RGD-reported genes appeared in our background network, and among 35 T2D-pathway genes hit in adipose-WDIN (seed genes), there are 0 overlaps. These 130 genes are pleasing test genes because we can verify our method through inspecting their rank indexes. Similarly, in muscle-WDIN, there are 36 genes from T2D-pathway (used as seed genes) and 169 RGD-reported genes respectively. In 169 RGD-reported genes, excluding the seed genes, there remains 146 genes which would be used as test genes for RWR. In liver-WDIN, there are 39 genes from T2D-pathway (used as seed genes) and 162 RGD-reported genes respectively. In 162 RGD-reported genes, excluding the overlap genes with seed genes, there remains 136 genes which would be used as test genes for RWR.

After random walking on the adipose-WDIN, the top 100 ranked candidates cover 16 test genes, top 200 covered 26, corresponding *p*-values tested by Fisher's exact are 0.0019 and 0.0147. The corresponding results are listed in [Table 3](#T3){ref-type="table"}, along with the similar results for the other two tissues. This indicated that our random walking on inferred WDINs can effectively prioritized the disease related genes.

###### 

We verify the efficiency of prioritized WDIN through Fisher's exact test.

  Tissue    Item                  Top100               All candidates       Top200   All candidates
  --------- --------------------- -------------------- -------------------- -------- ----------------
  Adipose   Test gene covered     18                   82                   29       171
            Test gene uncovered   120                  1593                 109      1504
            Fisher's exact        *p*-value = 0.0003   *p*-value = 0.0003            
  Muscle    Test gene covered     16                   84                   25       175
            Test gene uncovered   138                  1663                 129      1572
            Fisher's exact        *p*-value = 0.0069   *p*-value = 0.0198            
  Liver     Test gene covered     13                   87                   23       177
            Test gene uncovered   131                  1667                 121      1577
            Fisher's exact        *p*-value = 0.0492   *p*-value = 0.0336            
  Adipose   Test gene covered     16                   84                   26       174
            Test gene uncovered   114                  1591                 104      1501
            Fisher's exact        *p*-value = 0.0019   *p*-value = 0.0019            
  Muscle    Test gene covered     14                   86                   22       178
            Test gene uncovered   132                  1661                 124      1569
            Fisher's exact        *p*-value = 0.0310   *p*-value = 0.0490            
  Liver     Test gene covered     11                   89                   21       179
            Test gene uncovered   125                  1665                 115      1575
            Fisher's exact        *p*-value = 0.0989   *p*-value = 0.0435            

To collect more generally known T2D genes to verify our framework, we queried the approved type 2 diabetes genes through published papers from year 2010 to 2018. After mapping their homologous genes in rats based on the homologous categories from MGI ([@B6]), 12 genes were reserved. Finally, 8 of 12 genes were detected in three constructed WDINs which are respectively BCAR1, CAMK2B, CPS1, FADS2, GCK, PPARG, PDX1, and POLD2. Among them, GCK ([@B32]) and PDX1 ([@B22]) were included in our seed set. Besides, FADS2 ([@B27]) were ranked 112 in our prioritized adipose-WDIN (1,675 genes in total), and POLD2 ([@B15]) were ranked 98 in muscle-WDIN (1,747 genes in total). BCAR1 ([@B20]) and CAMK2B ([@B37]) also have higher ranks in muscle-WDIN which were 289 and 257 respectively. PPARG ([@B42]) was ranked 533 in adipose-WDIN, while CPS1 ([@B31]) had an unsatisfied rank 1,272. In general, the ranked results of these 8 genes were basically consistent with their published results associated with T2D. Furthermore, our results could offer tissue-specific insights into T2D.

### Cross-Tissue Functional Analysis Based on Prioritized Genes

In order to reduce the effect of ascertainment bias in genes loosely or less associated with the disease, we set a threshold, and only focused on the prioritized genes above this threshold in three tissue-dependent WDINs. Thus we can perform a local and more delicate functional analysis on tissue non-specific and tissue-specific genes among them separately with less noise. Our experiments show that the effect of the selection of the threshold is minor. If the threshold is too small such as less than 50, the genes chosen to perform functional enrichment analysis would be insufficient to achieve statistical significance; whereas if the threshold is too large such as higher than 200 (according to the results of the previous subsection), the follow-up functional analysis would be dilute on account of genes loosely associated with T2D. Therefore, we set a cutoff value for prioritized genes at 100 to conduct the cross-tissue functional analysis, and the results were shown in [Figure 5](#F5){ref-type="fig"}.

![Heatmap of top100 genes cross three prioritized WDINs. **(A)** For tissue non-specific genes. **(B)** For tissue-specific genes.](fgene-10-00252-g005){#F5}

We found that the enriched terms were more specific and striking with T2D when considering only the top100 prioritized housekeeping genes, such as type II diabetes mellitus, insulin signaling pathway, and glucose metabolic process. When restricting tissue-specific genes in the top100 prioritized genes, the tissue specificity became more visible. In detail, the immune effector process and positive regulation of phosphatidylinositol 3-kinase activity were not enriched in adipose, while specific genes in liver were not involved in negative regulation of transferase activity, positive regulation of phosphatidylinositol 3-kinase activity and epithelial cell differentiation process which also means that only adipose takes part in epithelial cell differentiation. When compared with the other two tissues, the muscle displays significant enrichment in regulation of kinase activity process and MAPK signaling pathway. And also from the overall view, the enriched functional items for adipose and muscle were closer.

### Characterizing the Molecular Functions of Each Predicted T2D-Associated Gene

After ranking candidates through random walking on tissue-dependent WDINs, we found that some genes were ranked ahead while they did not appear in the RGD database or T2D-pathway. For clarity, we focused on top50 nodes and considered them as potential T2D-associated genes. Below, we respectively list their gene information in [Table 4](#T4){ref-type="table"}, and corresponding pathway and process enrichment in [Table 5](#T5){ref-type="table"}.

###### 

Annotation on predicted potential T2D-assocaited genes.

  Tissue    Gene symbol   Rank index   Description
  --------- ------------- ------------ ------------------------------------------------------------
  Adipose   CARD9         2            Caspase recruitment domain family, member 9
            CHUK          9            Conserved helix-loop-helix ubiquitous kinase
            FBP1          6            Fructose-bisphosphatase 1
            FOS           7            Fos proto-oncogene, AP-1 transcription factor subunit
            GNB4          15           G protein subunit beta 4
            NFKBIB        4            NFKB inhibitor beta
            PGM1          3            Phosphoglucomutase 1
            PRPS1         12           Phosphoribosyl pyrophosphate synthetase 1
            RXRA          5            Retinoid X receptor alpha
            SHC1          10           SHC adaptor protein 1
            STAT4         1            Signal transducer and activator of transcription 4
  Muscle    ATP5O         12           ATP synthase peripheral stalk subunit OSCP
            CAMK2A        6            Calcium/calmodulin-dependent protein kinase II alpha
            GLB1          3            Galactosidase, beta 1
            MAP3K7        4            Mitogen activated protein kinase kinase kinase 7
            PDGFRA        11           Platelet derived growth factor receptor alpha
            PRKACB        5            Protein kinase cAMP-activated catalytic subunit beta
            RASGRF1       9            RAS protein-specific guanine nucleotide-releasing factor 1
            RPS6KA1       2            Ribosomal protein S6 kinase A1
            STAT4         7            Signal transducer and activator of transcription 4
  liver     CNTFR         5            Ciliary neurotrophic factor receptor
            GALM          8            Galactose mutarotase
            MAP2K7        9            Mitogen activated protein kinase kinase 7
            PSMD9         3            Proteasome 26S subunit, non-ATPase 9
            PTPN6         6            Protein tyrosine phosphatase, non-receptor type 6
            RASGRF1       1            RAS protein-specific guanine nucleotide-releasing factor 1
            RASGRF2       7            RAS protein-specific guanine nucleotide-releasing factor 2
            RASGRP2       10           RAS guanyl releasing protein 2
            RYR3          4            Ryanodine receptor 3

###### 

Key issues of motif enrichment analysis on predicted potential T2D-assocaited genes.

  Tissue    Category                  Description                                    Log10 (P)   Hit genes
  --------- ------------------------- ---------------------------------------------- ----------- ------------------------------------------
  Adipose   Reactome Gene Sets        Signaling by Interleukins                      −6.77       Nfkbib, Shc1, Chuk, Fos, Stat4
            KEGG Pathway              Th1 and Th2 cell differentiation               −6.64       Nfkbib, Chuk, Fos, Stat4
            KEGG Pathway              Pentose phosphate pathway                      −6.12       Fbp1, Pgm1, Prps1
            Reactome Gene Sets        Innate Immune System                           −5.75       Pgm1, Card9, Nfkbib, Shc1, Chuk, Fos
            KEGG Pathway              Chemokine signaling pathway                    −5.57       Nfkbib, Shc1, Gnb4, Chuk
            Reactome Gene Sets        Fc epsilon receptor signaling                  −4.63       Shc1, Chuk, Fos
            GO Biological Processes   Cellular response to insulin stimulus          −3.47       Fbp1, Rxra, Shc1
  Muscle    KEGG Pathway              MAPK signaling pathway                         −7.15       Pdgfra, Rps6ka1, Rasgrf1, Prkacb, Map3k7
            KEGG Pathway              Long-term potentiation                         −5.41       Camk2a, Rps6ka1, Prkacb
            KEGG Pathway              Wnt signaling pathway                          −4.38       Camk2a, Prkacb, Map3k7
            KEGG Pathway              Calcium signaling pathway                      −4.04       Pdgfra, Camk2a, Prkacb
  Liver     KEGG Pathway              MAPK signaling pathway                         −5.30       Rasgrf2, Rasgrf1, Rasgrp2, Map2k7
            GO Biological Processes   Regulation of cation transmembrane transport   −3.31       Rasgrf2, Ptpn6, Rasgrf1

According to the annotation of genes by Metascape, we found that some detected genes indeed have close connection with T2D. Among the top50 potential genes in adipose-WDIN, PGM1 mainly takes part in Pentose phosphate pathway and innate immune system and galactose catabolic process. FBP1 responses to insulin stimulus and pentose phosphate pathway. STAT4 was ranked in the top50 in both prioritized adipose- and muscle- WDINs respectively. This gene provides instructions for a protein that acts as a transcription factor, which means that it attaches (binds) to specific regions of DNA and helps control the activity of certain genes. The STAT4 protein is turned on (activated) by immune system proteins called cytokines, which are part of the inflammatory response to fight infection. RASGRF1 appears in potential T2D-associated gene set in both prioritized muscle- and liver- WDINs, and it has been shown to be upstream from IGF1 (Insulin-like growth factor 1) which is a star gene about T2D, allowing it to control growth in mice ([@B9]). PSMD9 was observed in top50 genes detected in liver-WDIN, and it plays an important role in negative regulation of insulin secretion processes (GO:0046676) and positive regulation of insulin secretion (GO:0032024); GALM is another potential T2D-related gene detected in liver-WDIN that acts as a part of the galactose catabolic process (GO:0019388) and the galactose metabolic process (GO:0006012).

These potential T2D-associated genes would be helpful for physicians or biologists, as they can be used to determine an experimental target as the subject of future research.

Module-Level Analysis for the Predicted T2D Associated Genes
------------------------------------------------------------

### Identifying Core Module From Prioritized WDIN Based on Edges

In addition to prioritizing candidate nodes, we further ranked interactions in three WDINs separately to capture those crucial interactions in several disorders caused by T2D. Specifically, each edge of the WDIN would be ranked according to the average rank of its corresponding two nodes. Theoretically, the edge having higher ranks (with smaller rank values) tends to have a closer association with the studied disease.

Our final goal was to identify a minimal set of prioritized WDIN edges which can reflect copious information about the disease in some tissues, namely 'core module' hereafter. To achieve this goal, we carried out a series of tests to evaluate the effectiveness of predicting and detecting disease related genes for the subnetworks from prioritized tissue-specific WDIN. Firstly, for each tissue, the series subnetworks were successively exacted from the prioritized WDIN based on edges from upon top 2.5% to upon top 25% at an internal of 2.5, and then the maximum connected component (MCC) of each subnetwork was retained for further analysis. In total, we had 10 MCCs for each tissue. Secondly, we compute the numbers and the coverage rates of the disease related genes collected from T2D-pathway and RGD database hit by each MCC ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}).

We then identified our core module through investigating the clustering coefficient of each MCC because the clustering coefficient can reflect the modular feature of biological function module ([@B8]). In most cases, a complex with larger clustering coefficient frequently tends to form a biological functional module. Generally, the clustering coefficient ranges from 0 to 1, and for a stochastic network with *N* nodes the value of it is approximately equal to *N*^−1^.

We calculated the clustering coefficient for each MCC and the corresponding results were listed in [Figure 6](#F6){ref-type="fig"}. Besides, we compute the clustering coefficients of three tissue-dependent WDINs which are 0.011, 0.011, and 0.016 for adipose, muscle, and liver respectively. For each tissue, the MCC with the largest clustering coefficient was selected as our core module, that is to say, top 15% of adipose-WDIN, top 17.5% of muscle-WDIN and top 12.5% of liver-WDIN are taken as our tissue-dependent core modules. It should be noted that the clustering coefficients (0.018, 0.013, and 0.021) belonging to three identified modules are all larger than that of their corresponding WDINs.

![Clustering coefficient of MCCs for each tissue.](fgene-10-00252-g006){#F6}

Analysis of core modules and a focus on the difference between the edges/interactions instead of nodes/genes individually would provide some important information from another viewpoint. We will illustrate this point in the next subsection.

### Creating Merged Core Module (MCM) Through Jaccard Index

Here we created the merged core module (MCM) by integrating three tissue-dependent core modules through introducing 'Jaccard index' ([@B21]). For each pair of core modules, we calculated the Jaccard index, which for a pair of sets is defined as the ratio between the size of the intersection and the size of the union of two sets. If the Jaccard index of an interaction is higher than a threshold in at least one pair of modules, we added this interaction to the merged core module along with their weights. To find a suitable threshold, we separately calculated a series of clustering coefficients of complexes which were generated when the threshold was set as 0.3, 0.2, 0.1, and 0.05, and the resulting clustering coefficients were 0, 0, 0.027, and 0.026. Hence, the parameter α = 0.1 was finalized as the best threshold to create our MCM. Finally, we had an MCM composed of 198 edges among 154 nodes.

We then investigated the inferred MCM to identify the specific and common components of dysfunctions between different tissues.

### Cross-Tissue Analysis Based on Merged Core Module

To systematically assess the extent to which the dysfunctions were shared among different tissues, we split the edges of MCM into three categories:

1.  Tissue-specific edge: the edge was significantly dysfunctional in only one tissue (as shown in [Figure 7](#F7){ref-type="fig"}). FIGURE 7Tissue-specific edges displayed in MCM. **(A)** Adipose. **(B)** Muscle. **(C)** Liver.

2.  Differential edge: the edge was significantly dysfunctional in at least two tissues. While their statuses were different, for example, the edge was active in tissue A whereas inactive in tissue B (shown in [Figure 8](#F8){ref-type="fig"}). FIGURE 8Differential edges displayed in MCM. The two subgraphs in each row show the differential edges between tissue I and tissue II. The different status between the tissue pair under T2D can be exhibited through the dysfunctional weight of the edge in different tissue-dependent WDIN. **(A,B)** Show the differential edges between adipose and muscle, respectively. **(C,D)** Show muscle and liver, respectively. **(E,F)** Show adipose and liver, respectively. The color and width of the edge here have the same meaning as in [Figure 7](#F7){ref-type="fig"}.

3.  Common edge: the edge was significantly dysfunctional in at least two tissues. When the status was consistent, for example, the edge was active in tissue A whereas inactive in tissue B (shown in [Figure 9](#F9){ref-type="fig"}). FIGURE 9Common edges displayed in MCM. The two subgraphs in each row show the common edges between two tissues. The consistent status between the tissue pair under T2D can be exhibited through the dysfunctional weight of the edge in different tissue-dependent WDIN. **(A,B)** Are the common edges between adipose and muscle, respectively. **(C,D)** Are for muscle and liver, respectively. **(E,F)** Show adipose and liver, respectively. The color and width of the edge here have the same meaning as in [Figure 7](#F7){ref-type="fig"}.

We found that in MCM, most adipose-specific edges appeared in links to hub gene PIK3R1, and a large proportion of them were active under T2D, such as the function occurred between PIK3R1 and INS1, the function between PIK3R1 and IRS2, the function between PIK3R1 and IGF1 etc. Taking muscle-specific edges in MCM into consideration, it can be seen that PIK3R1, PIK3CB, and EGFR were key nodes. The corresponding functions linked to PIK3R1 (such as the function occurred between PIK3R1 and IGF1R) were inactive which made the condition different than in adipose, and the corresponding functions around EGFR were active (such as functions linked between this node and IGF1). Though the distribution of liver-specific edges in MCM was decentralized when compared with other two tissues, PIK3R1 and PIK3CB were still two key nodes, interactions between PIK3R1 and other nodes (such as INS2) were active, while PIK3CB was a balanced node in terms of the hallmark of interactions.

There were 7 differential edges between adipose and muscle in MCM, which means the corresponding functions presented opposite status in these two tissues. As documented ([@B5]), GRB14 inhibited the catalytic activity of the INSR, which was identical to our result displayed in [Figure 8B](#F8){ref-type="fig"}. Actually, according to our result, this inhibition may have only emerged in muscle tissue, while it would be inverted in adipose tissue ([Figure 8A](#F8){ref-type="fig"}) This provides a meaningful target for biological experiments.

All 5 differential edges were identified between muscle and liver in MCM ([Figure 8C,D](#F8){ref-type="fig"}). Also from the visible changes in corresponding functions we could reveal more subtle and interesting difference between tissues. For example, as described in GeneCards^[3](#fn03){ref-type="fn"}^, SHC1 interacts with the NPXY motif of tyrosine-phosphorylated IGF1R. According to our results, we can further infer that the interaction was active in muscle under T2D while inhibited in liver. Some similar results would be observed between adipose and liver.

Inspecting the common edges between tissue pair, a notable thing was that all the four common interactions between adipose and liver were inactive. Remarkably, one of these four edges was between ABCC8 and KCNJ11, which are two well-known T2D-related genes encoding proteins Kir6.2 and Sur1, respectively, in pancreatic beta cells. KCNJ11 interacts with ABCC8 to produce the KATP channel, which transfers potassium ions across the beta cells ([@B16]). This interaction was indirectly linked through CACNA1E and was inhibited in both adipose and liver.

However, here we only described several edges for each category. Similar results can be examined from [Figure 6](#F6){ref-type="fig"}--[9](#F9){ref-type="fig"} which would be useful in studies about disease mechanism through analyzing the shared and specific components among tissues under the disease.

Discussion
==========

Type 2 diabetes (T2D) is a complex disease and its dysfunction involves many tissues. This work systematically investigates commonalities and specificities of T2D among multiple tissues. We established a multi-level comparative framework across three insulin target tissues (white adipose, skeletal muscle, and liver) to provide a better understanding of T2D.

The first challenge is to represent the tissues from the data. Starting from the ranks of gene expression, we constructed the 'disease network' through detecting diverse interactions to provide a well-characterization for disease affected tissues. Based on the constructed tissue-dependent WDINs, an elementary and integral comparative analysis at network-level was conducted. The results of network similarity according to the edges of network indicated that the similarity among three tissues is lower, thus justifying the necessity to conduct tissue-specific analysis for T2D. The differences among tissues were also visible in enriched motif based on tissue-specific genes, and these differences showed that some T2D-related pathways or biological processes own tissue specificity. Besides, we found that among three tissues, adipose and muscle have more similar components in terms of both enriched functions and network similarity.

To reduce the negative effects induced by genes loosely associated with T2D, RWRs algorithm was applied to the disease network to prioritize its nodes and edges according to their associations with T2D. Genes ranked higher theoretically are significantly associated with T2D. Gene-level analysis was carried out on those genes ranked higher such as in the top100. On one side, we discussed these genes individually and found that some of them have been reported to be related with disease genes, while several are not yet documented and could be potential T2D-related genes which may be further verified experimentally. On the other side, we collected these genes together to survey their combined functions through inspecting the enriched pathways and biological processes. Compared with the similar analysis based on the whole disease network, the analysis based on those closely associated with T2D displayed more specific and striking enriched issues with T2D (such as type II diabetes mellitus, insulin signaling pathway, and glucose metabolic process).

The network- and gene- level analyses could give some novel information cross tissues; meanwhile, they largely verified the effectiveness of our random walking on the constructed WDINs. Thus, based on the prioritized edges of WDINs, we further identified a merged core module (MCM) by combining the clustering coefficient and Jaccard index, which can provide and elaborate and visible explanation about the common and specific features for different tissues at module- level. Edges in the MCM were grouped into three categories: specific edges, differential edges, and common edges. Focusing on these three categories of edges, more detailed common issues and specific differences of dysfunctional functions between tissues were revealed which would enable us to further understand the disease. We await the emergence of tissue-specific and isoform-specific gene (specifically genes from IRs) knockout studies to corroborate these conclusions.

Overall, we presented a mathematical and systems biology framework consisting of constructing tissue-dependent disease related networks and multi-level analysis based on these constructed networks. Our network-, gene-, and module-level characterization across different tissues of T2D hold the promise to provide a broader and deeper understanding for T2D mechanism.
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